{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:47:25Z","timestamp":1772160445741,"version":"3.50.1"},"reference-count":31,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T00:00:00Z","timestamp":1294704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2011,2]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Reducing infectious morbidity is an important goal to improve childhood acute lymphoblastic leukaemia (ALL) survival. To explore the impact of chemotherapy reduction on infectious morbidity, we compared outpatient and inpatient infectious morbidity of reduced\n                    <jats:italic>versus<\/jats:italic>\n                    intensive (conventional) chemotherapy. One hundred and seventy\u2010one children newly diagnosed with ALL between 2004 and 2007 and treated according to the Dutch Childhood Oncology Group ALL 10 protocol were prospectively followed during the 2\u2010year treatment course. Stratified by minimal residual disease, 54 patients received reduced (standard risk; SR) and 117 patients received intensive (medium risk; MR) intensification\/maintenance treatment. SR outpatients had a median of 1 febrile episode\n                    <jats:italic>versus<\/jats:italic>\n                    4 in MR outpatients (\n                    <jats:italic>P\u2003<\/jats:italic>\n                    =\n                    <jats:italic>\u2003<\/jats:italic>\n                    0\u00b7002). SR patients had fewer hospitalizations for fever. They were admitted a median of 0 times, with a median of 0\u2003days of hospitalization, median 0\u2003days of fever, median 0 times chemotherapy interruption and median 0 times intravenous antibiotics. MR patients were admitted for fever median 2 times (\n                    <jats:italic>P\u2003<\/jats:italic>\n                    &lt;\n                    <jats:italic>\u2003<\/jats:italic>\n                    0\u00b7001) with 10\u2003days of hospitalization (\n                    <jats:italic>P\u2003<\/jats:italic>\n                    &lt;\n                    <jats:italic>\u2003<\/jats:italic>\n                    0\u00b7001), 2\u2003days of fever (\n                    <jats:italic>P\u2003<\/jats:italic>\n                    &lt;\n                    <jats:italic>\u2003<\/jats:italic>\n                    0\u00b7001), one chemotherapy interruption (\n                    <jats:italic>P\u2003<\/jats:italic>\n                    &lt;\n                    <jats:italic>\u2003<\/jats:italic>\n                    0\u00b7001) and two intravenous antibiotics administration (\n                    <jats:italic>P\u2003<\/jats:italic>\n                    &lt;\n                    <jats:italic>\u2003<\/jats:italic>\n                    0\u00b7001). These data indicate that reduced intensification\/maintenance compared to conventional intensive intensification\/maintenance chemotherapy for good risk childhood ALL resulted in major decrease of infectious morbidity.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2141.2010.08463.x","type":"journal-article","created":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T20:02:28Z","timestamp":1294776148000},"page":"433-440","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Impact of reduced chemotherapy treatment for good risk childhood acute lymphoblastic leukaemia on infectious morbidity*"],"prefix":"10.1111","volume":"152","author":[{"given":"Cornelis M.","family":"van Tilburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth A.M.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth E.","family":"Nibbelke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Revesz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Westers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom F.W.","family":"Wolfs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc B.","family":"Bierings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,11]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.8988"},{"key":"e_1_2_7_3_1","first-page":"31","article-title":"A study of illness in a group of Cleveland families. II. Incidence of the common respiratory diseases","volume":"58","author":"Badger G.F.","year":"1953","journal-title":"American Journal of Hygiene"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5063.119"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198712313172703"},{"key":"e_1_2_7_6_1","first-page":"138","volume-title":"Text Book of Pediatric Infectious Diseases 1","author":"Cherry J.D.","year":"2009"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08148.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-10-248146"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04058-6"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07862.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.5"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a121458"},{"key":"e_1_2_7_13_1","first-page":"CD004386","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","author":"Gafter\u2010Gvili A.","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_7_14_1","first-page":"259","article-title":"Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia","volume":"50","author":"Graubner U.B.","year":"2008","journal-title":"PediatricBlood & Cancer"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1082"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11353"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1086\/339215"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.258"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31817b0799"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70071-8"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07903.x"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08192.x"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0900386"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.252"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/137.1.14"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2007.07.002"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2008.12.009"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404326"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2010.10.005"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70228-1"},{"key":"e_1_2_7_31_1","first-page":"136","article-title":"Dexamethasone and Individualized Asparaginase Dosing Are Each Associated with Superior Event\u2010Free Survival in Childhood Acute Lymphoblastic Leukemia: results From DFCI\u2010ALL Concortium Protocol 00\u201001","volume":"114","author":"Vrooman L.M.","year":"2009","journal-title":"Blood (ASH meeting abstracts)"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-3955(05)70268-6"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2010.08463.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2010.08463.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T18:39:00Z","timestamp":1697395140000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2010.08463.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,11]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1111\/j.1365-2141.2010.08463.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08463.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.9066956.9641054","asserted-by":"object"}]},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,11]]},"assertion":[{"value":"2011-01-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}